Gephyrin anticorps (N-Term)
-
- Antigène Voir toutes Gephyrin (GPHN) Anticorps
- Gephyrin (GPHN)
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Gephyrin est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- Gephyrin antibody was raised against the N terminal of GPHN
- Purification
- Affinity purified
- Immunogène
- Gephyrin antibody was raised using the N terminal of GPHN corresponding to a region with amino acids HDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTED
- Top Product
- Discover our top product GPHN Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
Gephyrin Blocking Peptide, catalog no. 33R-3708, is also available for use as a blocking control in assays to test for specificity of this Gephyrin antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GPHN antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- Gephyrin (GPHN)
- Autre désignation
- Gephyrin (GPHN Produits)
- Synonymes
- anticorps 5730552E08Rik, anticorps AI662856, anticorps BC027112, anticorps C230040D23, anticorps GPH, anticorps GPHRYN, anticorps geph, anticorps Geph, anticorps GPHN, anticorps GEPH, anticorps HKPX1, anticorps gpgb1, anticorps DKFZp459M0825, anticorps gephyrin, anticorps gephyrin L homeolog, anticorps gephyrin a, anticorps Gphn, anticorps GPHN, anticorps gphn.L, anticorps gphna, anticorps PTRG_08978, anticorps VDBG_00775, anticorps Tsp_03043, anticorps gphn
- Sujet
- GPHN is a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described, however, the full-length nature of all transcript variants is not currently known.
- Poids moléculaire
- 80 kDa (MW of target protein)
- Pathways
- Synaptic Membrane, Skeletal Muscle Fiber Development
-